Summary
The global T-Cell Immunotherapy Market is expected to witness a CAGR of xx% over the forecast period 2021-2027 and is expected to reach US$ xx million in 2027, from US$ xx million in 2020.
T cell immunotherapy works by enhancing the immune system's ability to kill and detect cancer cells in the body. The way this works is based on the theory that antibodies or immune cells can identify and attack cancer cells on their own. T cell immunotherapy is commonly used to enhance the immune system of the body to kill cancer cells present in the bloodstream, the lymph nodes, lungs, bones, heart, and other vital organs. This therapy also helps to reduce the side effects of cancer treatments, such as fatigue, nausea, and swelling. It can be used in conjunction with chemotherapy, radiation, hormone therapy, surgery, and biological therapies.
Increasing use of immunotherapy in cancer treatment due to a higher success rate is propelling growth of the T cell immunotherapy market. According to the review by the U.S. National Library of Medicine 2017, up to 90% of people with a specific form of leukemia fully recovered from T cell immunotherapy. The Food and Drug Administration (FDA) Trusted Source approved the first CAR T cell therapy in 2017. Moreover, key players are investing heavily in the CAR-T therapies which is again projected to augment growth of the T cell immunotherapy market.
North America is expected to gain significant growth over the forecast period and this is attributed to the increasing FDA approval for novel T-cell immunotherapy. For instance, in March 2021, The U.S. Food and Drug Administration approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy
Key Developments:
- In July 2021, BioNTech SE and Kite, a Gilead Company announced the two companies have entered into a purchase agreement for BioNTech to acquire Kite’s solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility in Gaithersburg, MD
- In June 2021, Gene-editing biotech Intellia Therapeutics has partnered with Cellex Cell Professionals, to introduce a new startup that will develop immunotherapies for cancers and inflammatory diseases. That new company is backed by up to $250 million from Blackstone Life Sciences
- In August 2017, Novartis announced the US Food and Drug Administration (FDA) approval for Kymriah(TM) (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of with B-cell precursor acute lymphoblastic leukemia (ALL)
The T-Cell Immunotherapy Market report highlights product development and growth strategies such as mergers and acquisitions adopted by market players along with SWOT Analysis, PEST, and Porter’s Five Forces analyses of the T-Cell Immunotherapy Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Adaptimmune
- Altor Bioscience Corporation
- Cellectis
- Juno Therapeutics
- Kite Pharma
- Novartis
- Takara Bio
- Unum Therapeutics
By Product Type, the market is primarily segmented into:
By Applications, the market is segmented into:
- Stomach Cancer
- Lung Cancer
- Colorectal Cancer
- Esophagus Cancer
- Pancreatic Cancer
- Others
The report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
The objective of the T-Cell Immunotherapy Market Report:
- To assess the size of the market by value and volume
- Analyze the T-Cell Immunotherapy Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the T-Cell Immunotherapy Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of-the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact the growth of the T-Cell Immunotherapy Market
The T-Cell Immunotherapy Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the T-Cell Immunotherapy Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type, and application, 2020 are considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by T-Cell Immunotherapy Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global T-Cell Immunotherapy Market Share by Application: 2021 VS 2027
1.6 Coronavirus Disease 2019 (Covid-19) Impact: T-Cell Immunotherapy Market
1.6.1 How the Covid-19 is Affecting the T-Cell Immunotherapy Market
1.6.1.1 T-Cell Immunotherapy Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and T-Cell Immunotherapy Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 T-Cell Immunotherapy Market Perspective (2015-2027)
2.2 T-Cell Immunotherapy Market Growth Trends by Regions
2.2.1 T-Cell Immunotherapy Market Size by Regions: 2015 VS 2021 VS 2027
2.2.2 T-Cell Immunotherapy Market Historic Market Share by Regions (2015-2021)
2.2.3 T-Cell Immunotherapy Market Forecasted Market Size by Regions (2021-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 T-Cell Immunotherapy Market Growth Strategy
2.3.6 Primary Interviews with Key T-Cell Immunotherapy Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top T-Cell Immunotherapy Market Players by Market Size
3.1.1 Global Top T-Cell Immunotherapy Market Players by Revenue (2015-2021)
3.1.2 Global T-Cell Immunotherapy Market Revenue Market Share by Players (2015-2021)
3.1.3 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global T-Cell Immunotherapy Market Concentration Ratio
3.2.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Market Revenue in 2019
3.3 T-Cell Immunotherapy Market Key Players Head office and Area Served
3.4 Key Players T-Cell Immunotherapy Market Product Solution and Service
3.5 Date of entering into T-Cell Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2027)
4.1 Global T-Cell Immunotherapy Market Historic Market Size by Type (2015-2021)
4.2 Global T-Cell Immunotherapy Market Forecasted Market Size by Type (2021-2027)
5 T-Cell Immunotherapy Market Breakdown Data by Application (2015-2027)
5.1 Global T-Cell Immunotherapy Market Size by Application (2015-2021)
5.2 Global T-Cell Immunotherapy Market Forecasted Market Size by Application (2021-2027)
6 North America
6.1 North America T-Cell Immunotherapy Market Size (2015-2021)
6.2 T-Cell Immunotherapy Market Key Players in North America (2019-2021)
6.3 North America T-Cell Immunotherapy Market Size by Type (2015-2021)
6.4 North America T-Cell Immunotherapy Market Size by Application (2015-2021)
7 Europe
7.1 Europe T-Cell Immunotherapy Market Size (2015-2021)
7.2 T-Cell Immunotherapy Market Key Players in Europe (2019-2021)
7.3 Europe T-Cell Immunotherapy Market Size by Type (2015-2021)
7.4 Europe T-Cell Immunotherapy Market Size by Application (2015-2021)
8 China
8.1 China T-Cell Immunotherapy Market Size (2015-2021)
8.2 T-Cell Immunotherapy Market Key Players in China (2019-2021)
8.3 China T-Cell Immunotherapy Market Size by Type (2015-2021)
8.4 China T-Cell Immunotherapy Market Size by Application (2015-2021)
9 Japan
9.1 Japan T-Cell Immunotherapy Market Size (2015-2021)
9.2 T-Cell Immunotherapy Market Key Players in Japan (2019-2021)
9.3 Japan T-Cell Immunotherapy Market Size by Type (2015-2021)
9.4 Japan T-Cell Immunotherapy Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia T-Cell Immunotherapy Market Size (2015-2021)
10.2 T-Cell Immunotherapy Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia T-Cell Immunotherapy Market Size by Type (2015-2021)
10.4 Southeast Asia T-Cell Immunotherapy Market Size by Application (2015-2021)
11 India
11.1 India T-Cell Immunotherapy Market Size (2015-2021)
11.2 T-Cell Immunotherapy Market Key Players in India (2019-2021)
11.3 India T-Cell Immunotherapy Market Size by Type (2015-2021)
11.4 India T-Cell Immunotherapy Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America T-Cell Immunotherapy Market Size (2015-2021)
12.2 T-Cell Immunotherapy Market Key Players in Central & South America (2019-2021)
12.3 Central & South America T-Cell Immunotherapy Market Size by Type (2015-2021)
12.4 Central & South America T-Cell Immunotherapy Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 T-Cell Immunotherapy Market Introduction
13.4 T-Cell Immunotherapy Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. T-Cell Immunotherapy Market Key Market Segments
Table 2. Key Players Covered: Ranking by T-Cell Immunotherapy Market Revenue
Table 3. Ranking of Global Top T-Cell Immunotherapy Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for T-Cell Immunotherapy Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for T-Cell Immunotherapy Market Players to Combat Covid-19 Impact
Table 10. Global T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 11. Global T-Cell Immunotherapy Market Size by Regions (US$ Million): 2021 VS 2027
Table 12. Global T-Cell Immunotherapy Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global T-Cell Immunotherapy Market Share by Regions (2015-2021)
Table 14. Global T-Cell Immunotherapy Market Forecasted Market Size by Regions (2021-2027) (US$ Million)
Table 15. Global T-Cell Immunotherapy Market Share by Regions (2021-2027)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. T-Cell Immunotherapy Market Growth Strategy
Table 20. Main Points Interviewed from Key T-Cell Immunotherapy Market Players
Table 21. Global T-Cell Immunotherapy Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global T-Cell Immunotherapy Market Share by Players (2015-2021)
Table 23. Global Top T-Cell Immunotherapy Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Immunotherapy Market as of 2019)
Table 24. Global T-Cell Immunotherapy Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players T-Cell Immunotherapy Market Product Solution and Service
Table 27. Date of entering into T-Cell Immunotherapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global T-Cell Immunotherapy Market Size by Type (2015-2021) (Million US$)
Table 30. Global T-Cell Immunotherapy Market Size Share by Type (2015-2021)
Table 31. Global T-Cell Immunotherapy Market Revenue Market Share by Type (2021-2027)
Table 31. Global T-Cell Immunotherapy Market Size Share by Application (2015-2021)
Table 33. Global T-Cell Immunotherapy Market Size by Application (2015-2021) (Million US$)
Table 34. Global T-Cell Immunotherapy Market Size Share by Application (2021-2027)
Table 35. North America Key Players T-Cell Immunotherapy Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players T-Cell Immunotherapy Market Share (2019-2021)
Table 37. North America T-Cell Immunotherapy Market Size by Type (2015-2021) (Million US$)
Table 38. North America T-Cell Immunotherapy Market Share by Type (2015-2021)
Table 39. North America T-Cell Immunotherapy Market Size by Application (2015-2021) (Million US$)
Table 40. North America T-Cell Immunotherapy Market Share by Application (2015-2021)
Table 41. Europe Key Players T-Cell Immunotherapy Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players T-Cell Immunotherapy Market Share (2019-2021)
Table 43. Europe T-Cell Immunotherapy Market Size by Type (2015-2021) (Million US$)
Table 44. Europe T-Cell Immunotherapy Market Share by Type (2015-2021)
Table 45. Europe T-Cell Immunotherapy Market Size by Application (2015-2021) (Million US$)
Table 46. Europe T-Cell Immunotherapy Market Share by Application (2015-2021)
Table 47. China Key Players T-Cell Immunotherapy Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players T-Cell Immunotherapy Market Share (2019-2021)
Table 49. China T-Cell Immunotherapy Market Size by Type (2015-2021) (Million US$)
Table 50. China T-Cell Immunotherapy Market Share by Type (2015-2021)
Table 51. China T-Cell Immunotherapy Market Size by Application (2015-2021) (Million US$)
Table 52. China T-Cell Immunotherapy Market Share by Application (2015-2021)
Table 53. Japan Key Players T-Cell Immunotherapy Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players T-Cell Immunotherapy Market Share (2019-2021)
Table 55. Japan T-Cell Immunotherapy Market Size by Type (2015-2021) (Million US$)
Table 56. Japan T-Cell Immunotherapy Market Share by Type (2015-2021)
Table 57. Japan T-Cell Immunotherapy Market Size by Application (2015-2021) (Million US$)
Table 58. Japan T-Cell Immunotherapy Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players T-Cell Immunotherapy Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players T-Cell Immunotherapy Market Share (2019-2021)
Table 61. Southeast Asia T-Cell Immunotherapy Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia T-Cell Immunotherapy Market Share by Type (2015-2021)
Table 63. Southeast Asia T-Cell Immunotherapy Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia T-Cell Immunotherapy Market Share by Application (2015-2021)
Table 65. India Key Players T-Cell Immunotherapy Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players T-Cell Immunotherapy Market Share (2019-2021)
Table 67. India T-Cell Immunotherapy Market Size by Type (2015-2021) (Million US$)
Table 68. India T-Cell Immunotherapy Market Share by Type (2015-2021)
Table 69. India T-Cell Immunotherapy Market Size by Application (2015-2021) (Million US$)
Table 70. India T-Cell Immunotherapy Market Share by Application (2015-2021)
Table 71. Central & South America Key Players T-Cell Immunotherapy Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players T-Cell Immunotherapy Market Share (2019-2021)
Table 73. Central & South America T-Cell Immunotherapy Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America T-Cell Immunotherapy Market Share by Type (2015-2021)
Table 75. Central & South America T-Cell Immunotherapy Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America T-Cell Immunotherapy Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in T-Cell Immunotherapy Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global T-Cell Immunotherapy Market Share by Type: 2021 VS 2027
Figure 2. Global T-Cell Immunotherapy Market Share by Application: 2021 VS 2027
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. T-Cell Immunotherapy Market Report Years Considered
Figure 8. Global T-Cell Immunotherapy Market Size YoY Growth 2015-2027 (US$ Million)
Figure 9. Global T-Cell Immunotherapy Market Share by Regions: 2021 VS 2027
Figure 10. Global T-Cell Immunotherapy Market Share by Regions (2021-2027)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global T-Cell Immunotherapy Market Share by Players in 2019
Figure 13. Global Top T-Cell Immunotherapy Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in T-Cell Immunotherapy Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by T-Cell Immunotherapy Market Revenue in 2019
Figure 15. North America T-Cell Immunotherapy Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe T-Cell Immunotherapy Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China T-Cell Immunotherapy Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan T-Cell Immunotherapy Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia T-Cell Immunotherapy Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India T-Cell Immunotherapy Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America T-Cell Immunotherapy Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
